Suprecur nasal spray
Country: New Zealand
Lingwa: Ingliż
Sors: Medsafe (Medicines Safety Authority)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Buserelin acetate 1.575 mg/g equivalent to 1.50 mg/mL Buserelin
Disponibbli minn:
sanofi-aventis new zealand limited
INN (Isem Internazzjonali):
Buserelin acetate 1.575 mg/g (= 1.50 mg/mL Buserelin)
Dożaġġ:
150 mcg/dose
Għamla farmaċewtika:
Nasal spray solution
Kompożizzjoni:
Active: Buserelin acetate 1.575 mg/g equivalent to 1.50 mg/mL Buserelin Excipient: Benzalkonium chloride Citric acid monohydrate Sodium chloride Sodium citrate dihydrate Water for injection
Unitajiet fil-pakkett:
Bottle, glass, 2 x 100 spray doses, 200 dose units
Klassi:
Prescription
Tip ta 'preskrizzjoni:
Prescription
Manifatturat minn:
Sanofi-Aventis Deutschland GmbH
Sommarju tal-prodott:
Package - Contents - Shelf Life: Bottle, glass, 2 x 100 spray doses - 200 dose units - 36 months from date of manufacture stored at or below 25°C
Data ta 'l-awtorizzazzjoni:
1993-03-26
